

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.26319035 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.26319035 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.82829027 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.82829027 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.51573738 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.34435924 |
| 7 | bile acid biosynthetic process (GO:0006699) | 5.00452696 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 4.86074016 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.84814663 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.84814663 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.84814663 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.75950590 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 4.61391389 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.59051826 |
| 15 | urea cycle (GO:0000050) | 4.52903126 |
| 16 | urea metabolic process (GO:0019627) | 4.52903126 |
| 17 | glyoxylate metabolic process (GO:0046487) | 4.46753337 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.42393123 |
| 19 | protein carboxylation (GO:0018214) | 4.42393123 |
| 20 | complement activation, alternative pathway (GO:0006957) | 4.42295924 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 4.38991073 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 4.36842671 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 4.36249058 |
| 24 | bile acid metabolic process (GO:0008206) | 4.35767607 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.30031873 |
| 26 | cysteine metabolic process (GO:0006534) | 4.28029374 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.26585319 |
| 28 | reverse cholesterol transport (GO:0043691) | 4.20216399 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.15330233 |
| 30 | protein-lipid complex remodeling (GO:0034368) | 4.08324973 |
| 31 | macromolecular complex remodeling (GO:0034367) | 4.08324973 |
| 32 | plasma lipoprotein particle remodeling (GO:0034369) | 4.08324973 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.07245457 |
| 34 | regulation of complement activation (GO:0030449) | 4.02405498 |
| 35 | phospholipid efflux (GO:0033700) | 4.01196291 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.99327759 |
| 37 | cellular ketone body metabolic process (GO:0046950) | 3.98382722 |
| 38 | tyrosine metabolic process (GO:0006570) | 3.97064307 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 3.93038789 |
| 40 | homocysteine metabolic process (GO:0050667) | 3.90500317 |
| 41 | acylglycerol homeostasis (GO:0055090) | 3.86442434 |
| 42 | triglyceride homeostasis (GO:0070328) | 3.86442434 |
| 43 | bile acid and bile salt transport (GO:0015721) | 3.85094612 |
| 44 | glutamate metabolic process (GO:0006536) | 3.85022177 |
| 45 | cholesterol efflux (GO:0033344) | 3.78643359 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 3.74948206 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 3.74633094 |
| 48 | plasma lipoprotein particle clearance (GO:0034381) | 3.73857155 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 3.72825263 |
| 50 | negative regulation of sterol transport (GO:0032372) | 3.72825263 |
| 51 | cellular glucuronidation (GO:0052695) | 3.71744879 |
| 52 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.70087438 |
| 53 | lysine metabolic process (GO:0006553) | 3.67879611 |
| 54 | lysine catabolic process (GO:0006554) | 3.67879611 |
| 55 | coenzyme catabolic process (GO:0009109) | 3.65000204 |
| 56 | low-density lipoprotein particle remodeling (GO:0034374) | 3.54055896 |
| 57 | drug catabolic process (GO:0042737) | 3.51531545 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 3.48950723 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 3.48631831 |
| 60 | ketone body metabolic process (GO:1902224) | 3.44907801 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 3.43895050 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 3.43321178 |
| 63 | benzene-containing compound metabolic process (GO:0042537) | 3.42898306 |
| 64 | plasma lipoprotein particle assembly (GO:0034377) | 3.40912558 |
| 65 | uronic acid metabolic process (GO:0006063) | 3.36940352 |
| 66 | glucuronate metabolic process (GO:0019585) | 3.36940352 |
| 67 | regulation of bile acid biosynthetic process (GO:0070857) | 3.35217771 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 3.33906589 |
| 69 | phospholipid homeostasis (GO:0055091) | 3.31846698 |
| 70 | short-chain fatty acid metabolic process (GO:0046459) | 3.30575753 |
| 71 | positive regulation of lipid catabolic process (GO:0050996) | 3.29684369 |
| 72 | amine catabolic process (GO:0009310) | 3.28676621 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 3.28676621 |
| 74 | fibrinolysis (GO:0042730) | 3.25561199 |
| 75 | negative regulation of lipase activity (GO:0060192) | 3.24846232 |
| 76 | ethanol oxidation (GO:0006069) | 3.22608631 |
| 77 | macroautophagy (GO:0016236) | 3.18946543 |
| 78 | plasma lipoprotein particle organization (GO:0071827) | 3.16366920 |
| 79 | arginine metabolic process (GO:0006525) | 3.15397978 |
| 80 | protein-lipid complex assembly (GO:0065005) | 3.13840468 |
| 81 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13184054 |
| 82 | drug transmembrane transport (GO:0006855) | 3.11971128 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.11483104 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.11483104 |
| 85 | cholesterol homeostasis (GO:0042632) | 3.08569686 |
| 86 | sterol homeostasis (GO:0055092) | 3.07732096 |
| 87 | opsonization (GO:0008228) | 3.07301806 |
| 88 | cofactor catabolic process (GO:0051187) | 3.06801197 |
| 89 | carboxylic acid catabolic process (GO:0046395) | 3.03722472 |
| 90 | organic acid catabolic process (GO:0016054) | 3.03722472 |
| 91 | imidazole-containing compound metabolic process (GO:0052803) | 3.03484707 |
| 92 | lipoprotein metabolic process (GO:0042157) | 3.03354172 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.02882616 |
| 94 | complement activation, classical pathway (GO:0006958) | 3.02525182 |
| 95 | protein-lipid complex subunit organization (GO:0071825) | 3.02231232 |
| 96 | exogenous drug catabolic process (GO:0042738) | 3.01115757 |
| 97 | complement activation (GO:0006956) | 3.00797446 |
| 98 | intestinal cholesterol absorption (GO:0030299) | 2.99626287 |
| 99 | cytolysis (GO:0019835) | 2.98394656 |
| 100 | flavonoid metabolic process (GO:0009812) | 2.96743140 |
| 101 | protein activation cascade (GO:0072376) | 2.95476280 |
| 102 | epoxygenase P450 pathway (GO:0019373) | 2.90902280 |
| 103 | negative regulation of protein activation cascade (GO:2000258) | 2.73557910 |
| 104 | nerve growth factor signaling pathway (GO:0038180) | 2.67582706 |
| 105 | negative regulation of complement activation (GO:0045916) | 2.64047696 |
| 106 | cellular response to ethanol (GO:0071361) | 2.60349850 |
| 107 | carnitine shuttle (GO:0006853) | 2.33549836 |
| 108 | amino-acid betaine transport (GO:0015838) | 2.30954979 |
| 109 | carnitine transport (GO:0015879) | 2.30954979 |
| 110 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.28352204 |
| 111 | negative regulation of humoral immune response (GO:0002921) | 2.27633206 |
| 112 | carnitine transmembrane transport (GO:1902603) | 2.25551457 |
| 113 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.23453306 |
| 114 | positive regulation of Rap GTPase activity (GO:0032854) | 2.19318013 |
| 115 | omega-hydroxylase P450 pathway (GO:0097267) | 2.18128939 |
| 116 | regulation of ARF protein signal transduction (GO:0032012) | 2.16696008 |
| 117 | negative regulation of fatty acid transport (GO:2000192) | 2.06571044 |
| 118 | quaternary ammonium group transport (GO:0015697) | 2.04747388 |
| 119 | histone H3-K36 demethylation (GO:0070544) | 2.03213697 |
| 120 | fatty acid transmembrane transport (GO:1902001) | 2.02351536 |
| 121 | ethanol metabolic process (GO:0006067) | 2.01433980 |
| 122 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.99955565 |
| 123 | intestinal absorption (GO:0050892) | 1.99893384 |
| 124 | regulation of energy homeostasis (GO:2000505) | 1.97152579 |
| 125 | positive regulation of fatty acid oxidation (GO:0046321) | 1.96934036 |
| 126 | mannose metabolic process (GO:0006013) | 1.93633697 |
| 127 | establishment of protein localization to Golgi (GO:0072600) | 1.91713114 |
| 128 | Rap protein signal transduction (GO:0032486) | 1.90633018 |
| 129 | alkaloid metabolic process (GO:0009820) | 1.90295620 |
| 130 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.90268565 |
| 131 | negative regulation of neurotransmitter secretion (GO:0046929) | 1.88508256 |
| 132 | protein targeting to Golgi (GO:0000042) | 1.87530997 |
| 133 | regulation of Rap GTPase activity (GO:0032317) | 1.87084756 |
| 134 | germinal center formation (GO:0002467) | 1.86988446 |
| 135 | phospholipid translocation (GO:0045332) | 1.86848794 |
| 136 | lipid translocation (GO:0034204) | 1.86848794 |
| 137 | positive regulation of extracellular matrix organization (GO:1903055) | 1.86753631 |
| 138 | acute-phase response (GO:0006953) | 1.86099047 |
| 139 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 1.85955878 |
| 140 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 1.84795671 |
| 141 | positive regulation of glycolytic process (GO:0045821) | 1.84364095 |
| 142 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 1.84081247 |
| 143 | response to nerve growth factor (GO:1990089) | 1.81614404 |
| 144 | cellular response to nerve growth factor stimulus (GO:1990090) | 1.81614404 |
| 145 | growth hormone receptor signaling pathway (GO:0060396) | 1.81338077 |
| 146 | sodium ion homeostasis (GO:0055078) | 1.80731708 |
| 147 | striated muscle atrophy (GO:0014891) | 1.79319963 |
| 148 | Golgi to endosome transport (GO:0006895) | 1.78779423 |
| 149 | drug metabolic process (GO:0017144) | 1.78622305 |
| 150 | negative regulation of inclusion body assembly (GO:0090084) | 1.78471171 |
| 151 | lipoprotein transport (GO:0042953) | 1.76590272 |
| 152 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 1.74308013 |
| 153 | cellular response to epinephrine stimulus (GO:0071872) | 1.74134331 |
| 154 | regulation of lipid catabolic process (GO:0050994) | 1.73636784 |
| 155 | diacylglycerol metabolic process (GO:0046339) | 1.73470746 |
| 156 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 1.73174488 |
| 157 | interleukin-6-mediated signaling pathway (GO:0070102) | 1.72095944 |
| 158 | negative regulation of lipid transport (GO:0032369) | 1.71019784 |
| 159 | regulation of humoral immune response (GO:0002920) | 1.70500371 |
| 160 | maintenance of gastrointestinal epithelium (GO:0030277) | 1.70275751 |
| 161 | negative regulation of hemostasis (GO:1900047) | 1.70199279 |
| 162 | negative regulation of blood coagulation (GO:0030195) | 1.70199279 |
| 163 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 1.69652342 |
| 164 | relaxation of cardiac muscle (GO:0055119) | 1.69637989 |
| 165 | skeletal muscle adaptation (GO:0043501) | 1.69239271 |
| 166 | regulation of fatty acid beta-oxidation (GO:0031998) | 1.67692542 |
| 167 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 1.67025177 |
| 168 | negative regulation of B cell mediated immunity (GO:0002713) | 1.67025177 |
| 169 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.66633769 |
| 170 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 1.66632875 |
| 171 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 1.66015567 |
| 172 | cellular response to fluid shear stress (GO:0071498) | 1.65786605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.34916423 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.34838850 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.45606630 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.42023108 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.11916059 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.61038228 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.94582909 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79948367 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.56747410 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23747446 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.93008655 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87716368 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85006990 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59635406 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58455465 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49900318 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49460369 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.49283525 |
| 19 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42155580 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37091861 |
| 21 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32783392 |
| 22 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32783392 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30694180 |
| 24 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29787055 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27552307 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27294588 |
| 27 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26497552 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25728689 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25585772 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24970525 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24765218 |
| 32 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.20180368 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19285417 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17377302 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16950982 |
| 36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16472322 |
| 37 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15674710 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13472297 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13463858 |
| 40 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12111318 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12052697 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11217481 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10009702 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09006851 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08702884 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08317082 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08139815 |
| 48 | TP53_16413492_ChIP-PET_HCT116_Human | 1.07316930 |
| 49 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06775116 |
| 50 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06253228 |
| 51 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05942279 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05126476 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03852350 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03650148 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02210396 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01540080 |
| 57 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00603692 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00323449 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00063897 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99629323 |
| 61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98175297 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97822145 |
| 63 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96602184 |
| 64 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95061665 |
| 65 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94893541 |
| 66 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93893466 |
| 67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.92962125 |
| 68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92557578 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.92557075 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91810031 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90620752 |
| 72 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.90458836 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89648646 |
| 74 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89376815 |
| 75 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.89212329 |
| 76 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.89212329 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88620763 |
| 78 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87966195 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87468088 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87364983 |
| 81 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86501561 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85520003 |
| 83 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84090744 |
| 84 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.83870492 |
| 85 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83712104 |
| 86 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.83701857 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83408500 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83405426 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83268501 |
| 90 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82835353 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82726249 |
| 92 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82710771 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82583098 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82489019 |
| 95 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82305207 |
| 96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82053919 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81915302 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81161632 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80785696 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80755870 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80718907 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80346588 |
| 103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80192275 |
| 104 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.78375680 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77600060 |
| 106 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76868688 |
| 107 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76805752 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76674098 |
| 109 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76417204 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76084144 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75783907 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75716752 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 0.75629156 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75397053 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75327547 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.74776394 |
| 117 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.74675291 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74168423 |
| 119 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.73676409 |
| 120 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.73455223 |
| 121 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.73385578 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73314637 |
| 123 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.73137946 |
| 124 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.72689515 |
| 125 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.72282779 |
| 126 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.72031295 |
| 127 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72007329 |
| 128 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71563394 |
| 129 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71407757 |
| 130 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.71083052 |
| 131 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.70954159 |
| 132 | STAT3_23295773_ChIP-Seq_U87_Human | 0.70847458 |
| 133 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.70661977 |
| 134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.70002190 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.68919638 |
| 136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68090947 |
| 137 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.68059246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.39371193 |
| 2 | MP0005360_urolithiasis | 6.75765739 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.86813790 |
| 4 | MP0005365_abnormal_bile_salt | 5.48072273 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.63054086 |
| 6 | MP0003252_abnormal_bile_duct | 3.71175559 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.24542777 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.95007221 |
| 9 | MP0003195_calcinosis | 2.76547738 |
| 10 | MP0009840_abnormal_foam_cell | 2.71004629 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.69692141 |
| 12 | MP0005083_abnormal_biliary_tract | 2.67317339 |
| 13 | MP0005332_abnormal_amino_acid | 2.51896043 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.26503187 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.16097174 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.06345511 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 1.95165063 |
| 18 | MP0003868_abnormal_feces_composition | 1.94967812 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.83834432 |
| 20 | MP0000609_abnormal_liver_physiology | 1.83334854 |
| 21 | MP0003045_fibrosis | 1.75925932 |
| 22 | MP0005409_darkened_coat_color | 1.75193885 |
| 23 | MP0002009_preneoplasia | 1.70671532 |
| 24 | MP0003303_peritoneal_inflammation | 1.69171863 |
| 25 | MP0004484_altered_response_of | 1.68926901 |
| 26 | MP0003828_pulmonary_edema | 1.56028659 |
| 27 | MP0000604_amyloidosis | 1.53696780 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49724470 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.47341516 |
| 30 | MP0004084_abnormal_cardiac_muscle | 1.42042113 |
| 31 | MP0002822_catalepsy | 1.39224426 |
| 32 | MP0003436_decreased_susceptibility_to | 1.38061090 |
| 33 | MP0003329_amyloid_beta_deposits | 1.34946158 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.34345012 |
| 35 | MP0005670_abnormal_white_adipose | 1.32786323 |
| 36 | MP0003879_abnormal_hair_cell | 1.29885454 |
| 37 | MP0004510_myositis | 1.28281478 |
| 38 | MP0003690_abnormal_glial_cell | 1.27798758 |
| 39 | MP0003866_abnormal_defecation | 1.24606278 |
| 40 | MP0008004_abnormal_stomach_pH | 1.23482339 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.21214239 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.20981584 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.20894314 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.19080226 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.18350505 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.15499649 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.14321414 |
| 48 | MP0001764_abnormal_homeostasis | 1.14111383 |
| 49 | MP0005451_abnormal_body_composition | 1.11998464 |
| 50 | MP0002254_reproductive_system_inflammat | 1.10462364 |
| 51 | MP0004130_abnormal_muscle_cell | 1.09234163 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.08503230 |
| 53 | MP0009764_decreased_sensitivity_to | 1.08298473 |
| 54 | MP0001664_abnormal_digestion | 1.05941350 |
| 55 | MP0009697_abnormal_copulation | 1.05753575 |
| 56 | MP0009115_abnormal_fat_cell | 1.02987373 |
| 57 | MP0001851_eye_inflammation | 1.02068009 |
| 58 | MP0005535_abnormal_body_temperature | 1.01658626 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 1.01552284 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.99603456 |
| 61 | MP0006138_congestive_heart_failure | 0.99084662 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 0.96999587 |
| 63 | MP0004215_abnormal_myocardial_fiber | 0.95642007 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.91869707 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 0.91540727 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.91169100 |
| 67 | MP0003075_altered_response_to | 0.89888859 |
| 68 | MP0004270_analgesia | 0.89443416 |
| 69 | MP0002837_dystrophic_cardiac_calcinosis | 0.88807509 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 0.88071103 |
| 71 | MP0005647_abnormal_sex_gland | 0.88062065 |
| 72 | MP0003091_abnormal_cell_migration | 0.86604840 |
| 73 | MP0000249_abnormal_blood_vessel | 0.86322961 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.84557701 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.84240735 |
| 76 | MP0002638_abnormal_pupillary_reflex | 0.81160863 |
| 77 | MP0005166_decreased_susceptibility_to | 0.79916695 |
| 78 | MP0005334_abnormal_fat_pad | 0.79910449 |
| 79 | MP0004043_abnormal_pH_regulation | 0.79679013 |
| 80 | MP0005310_abnormal_salivary_gland | 0.79380918 |
| 81 | MP0002909_abnormal_adrenal_gland | 0.79278582 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.79215778 |
| 83 | MP0002971_abnormal_brown_adipose | 0.78570697 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.78551342 |
| 85 | MP0005448_abnormal_energy_balance | 0.77872612 |
| 86 | MP0000598_abnormal_liver_morphology | 0.77700709 |
| 87 | MP0004947_skin_inflammation | 0.77042728 |
| 88 | MP0005408_hypopigmentation | 0.76953336 |
| 89 | MP0009763_increased_sensitivity_to | 0.76515355 |
| 90 | MP0005423_abnormal_somatic_nervous | 0.74497848 |
| 91 | MP0001440_abnormal_grooming_behavior | 0.73743938 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.73402833 |
| 93 | MP0002090_abnormal_vision | 0.73208839 |
| 94 | MP0005620_abnormal_muscle_contractility | 0.72608483 |
| 95 | MP0010368_abnormal_lymphatic_system | 0.71977346 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.71540829 |
| 97 | MP0001756_abnormal_urination | 0.70776319 |
| 98 | MP0003011_delayed_dark_adaptation | 0.69721129 |
| 99 | MP0009785_altered_susceptibility_to | 0.69658683 |
| 100 | MP0008469_abnormal_protein_level | 0.69370497 |
| 101 | MP0008569_lethality_at_weaning | 0.67598925 |
| 102 | MP0000920_abnormal_myelination | 0.67585101 |
| 103 | MP0009384_cardiac_valve_regurgitation | 0.67393100 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.66969543 |
| 105 | MP0010678_abnormal_skin_adnexa | 0.66207458 |
| 106 | MP0008874_decreased_physiological_sensi | 0.66093628 |
| 107 | MP0001800_abnormal_humoral_immune | 0.65959949 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.62798739 |
| 109 | MP0003633_abnormal_nervous_system | 0.62641093 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.61668374 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.61631307 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.60999500 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.58633798 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.57345574 |
| 115 | MP0001984_abnormal_olfaction | 0.57178625 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.55221459 |
| 117 | MP0003186_abnormal_redox_activity | 0.55191419 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.54932534 |
| 119 | MP0004885_abnormal_endolymph | 0.53755322 |
| 120 | MP0001501_abnormal_sleep_pattern | 0.52671325 |
| 121 | MP0003953_abnormal_hormone_level | 0.52186103 |
| 122 | MP0001661_extended_life_span | 0.50564716 |
| 123 | MP0004859_abnormal_synaptic_plasticity | 0.50391538 |
| 124 | MP0005187_abnormal_penis_morphology | 0.49514209 |
| 125 | MP0002168_other_aberrant_phenotype | 0.49445502 |
| 126 | MP0004883_abnormal_blood_vessel | 0.48174208 |
| 127 | MP0006082_CNS_inflammation | 0.47302784 |
| 128 | MP0009745_abnormal_behavioral_response | 0.46248883 |
| 129 | MP0003631_nervous_system_phenotype | 0.46138873 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.44807619 |
| 131 | MP0005164_abnormal_response_to | 0.44014901 |
| 132 | MP0002928_abnormal_bile_duct | 0.43795346 |
| 133 | MP0002064_seizures | 0.43526380 |
| 134 | MP0002295_abnormal_pulmonary_circulatio | 0.43152914 |
| 135 | MP0003632_abnormal_nervous_system | 0.42921071 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.42203295 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.41878038 |
| 138 | MP0000579_abnormal_nail_morphology | 0.41814385 |
| 139 | * MP0003635_abnormal_synaptic_transmissio | 0.40993005 |
| 140 | MP0003724_increased_susceptibility_to | 0.40962911 |
| 141 | MP0002136_abnormal_kidney_physiology | 0.40546663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.59661070 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.50655351 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.30784375 |
| 4 | Xanthomatosis (HP:0000991) | 5.69954357 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.64201540 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.54495817 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.27463932 |
| 8 | Complement deficiency (HP:0004431) | 5.04842874 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.87479987 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.16989446 |
| 11 | Epidermoid cyst (HP:0200040) | 4.12736835 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.05664569 |
| 13 | Fat malabsorption (HP:0002630) | 3.99566035 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 3.97816626 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.94896622 |
| 16 | Joint hemorrhage (HP:0005261) | 3.90167023 |
| 17 | Hyperammonemia (HP:0001987) | 3.83450511 |
| 18 | Ketosis (HP:0001946) | 3.80581387 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.74798403 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.66245583 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.63433526 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.59562649 |
| 23 | Abnormality of complement system (HP:0005339) | 3.53495607 |
| 24 | Hyperglycinemia (HP:0002154) | 3.48287519 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.43040601 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.39897580 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37030946 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.21324436 |
| 29 | Myocardial infarction (HP:0001658) | 3.13112571 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.11813173 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.11813173 |
| 32 | Hyperglycinuria (HP:0003108) | 3.11054388 |
| 33 | Ketoacidosis (HP:0001993) | 2.98767628 |
| 34 | Febrile seizures (HP:0002373) | 2.98275186 |
| 35 | Steatorrhea (HP:0002570) | 2.94916933 |
| 36 | Papilledema (HP:0001085) | 2.84112357 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.79453780 |
| 38 | Hypoglycemic seizures (HP:0002173) | 2.76153223 |
| 39 | Skin nodule (HP:0200036) | 2.75786486 |
| 40 | Hyperbilirubinemia (HP:0002904) | 2.75654393 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.73433442 |
| 42 | Spontaneous abortion (HP:0005268) | 2.72491121 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.70670367 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 2.69679976 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.65562743 |
| 46 | Glomerulonephritis (HP:0000099) | 2.57626196 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.54665174 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.45689509 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.43683049 |
| 50 | Decreased circulating renin level (HP:0003351) | 2.42823272 |
| 51 | Amyloidosis (HP:0011034) | 2.41645777 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.40232067 |
| 53 | Vascular calcification (HP:0004934) | 2.37041978 |
| 54 | Metabolic acidosis (HP:0001942) | 2.36810526 |
| 55 | Acanthocytosis (HP:0001927) | 2.36516291 |
| 56 | Sensorimotor neuropathy (HP:0007141) | 2.34751116 |
| 57 | Hyperkalemia (HP:0002153) | 2.34231618 |
| 58 | Mitral stenosis (HP:0001718) | 2.31896912 |
| 59 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.30028210 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.29730409 |
| 61 | Neurofibrillary tangles (HP:0002185) | 2.29477280 |
| 62 | Bundle branch block (HP:0011710) | 2.28036230 |
| 63 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.27893620 |
| 64 | Gout (HP:0001997) | 2.27659204 |
| 65 | Papillary thyroid carcinoma (HP:0002895) | 2.25402778 |
| 66 | Ventricular fibrillation (HP:0001663) | 2.25366362 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.24562175 |
| 68 | Esophageal varix (HP:0002040) | 2.17992857 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17890164 |
| 70 | Syncope (HP:0001279) | 2.17886540 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.17879470 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.17879470 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.17805092 |
| 74 | Hypophosphatemic rickets (HP:0004912) | 2.16624607 |
| 75 | Irritability (HP:0000737) | 2.14891301 |
| 76 | Metabolic alkalosis (HP:0200114) | 2.14848990 |
| 77 | Aortic aneurysm (HP:0004942) | 2.14387547 |
| 78 | Abnormal gallbladder morphology (HP:0012437) | 2.13652503 |
| 79 | Right ventricular cardiomyopathy (HP:0011663) | 2.12904338 |
| 80 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.11365855 |
| 81 | Ankle clonus (HP:0011448) | 2.07495016 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.05342465 |
| 83 | Cerebral inclusion bodies (HP:0100314) | 2.05215394 |
| 84 | Hyperactive renin-angiotensin system (HP:0000841) | 2.02430933 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.01664274 |
| 86 | Malnutrition (HP:0004395) | 1.99565886 |
| 87 | Lethargy (HP:0001254) | 1.99085547 |
| 88 | Postural instability (HP:0002172) | 1.98958414 |
| 89 | Cholecystitis (HP:0001082) | 1.98531828 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 1.98531828 |
| 91 | Hemorrhage of the eye (HP:0011885) | 1.98463356 |
| 92 | Neonatal onset (HP:0003623) | 1.98043486 |
| 93 | Rickets (HP:0002748) | 1.97861312 |
| 94 | Cholelithiasis (HP:0001081) | 1.97228609 |
| 95 | Status epilepticus (HP:0002133) | 1.94698355 |
| 96 | Spastic diplegia (HP:0001264) | 1.94026152 |
| 97 | Abnormality of renin-angiotensin system (HP:0000847) | 1.93583647 |
| 98 | Symptomatic seizures (HP:0011145) | 1.92973713 |
| 99 | Confusion (HP:0001289) | 1.92879055 |
| 100 | Pigmentary retinal degeneration (HP:0001146) | 1.92597937 |
| 101 | Pancreatitis (HP:0001733) | 1.92330897 |
| 102 | Ulnar claw (HP:0001178) | 1.88428800 |
| 103 | Hyperglycemia (HP:0003074) | 1.86769535 |
| 104 | Protuberant abdomen (HP:0001538) | 1.85207990 |
| 105 | Cerebral hemorrhage (HP:0001342) | 1.84683500 |
| 106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84392166 |
| 107 | Abnormality of chloride homeostasis (HP:0011422) | 1.84314500 |
| 108 | Enlarged kidneys (HP:0000105) | 1.82795940 |
| 109 | Gingival bleeding (HP:0000225) | 1.82561190 |
| 110 | Muscle fiber splitting (HP:0003555) | 1.81764671 |
| 111 | Onion bulb formation (HP:0003383) | 1.81142805 |
| 112 | Hyperventilation (HP:0002883) | 1.80223700 |
| 113 | Late onset (HP:0003584) | 1.79807573 |
| 114 | Sudden death (HP:0001699) | 1.79240768 |
| 115 | Arthropathy (HP:0003040) | 1.78798368 |
| 116 | Increased CSF protein (HP:0002922) | 1.78459797 |
| 117 | Alkalosis (HP:0001948) | 1.78297827 |
| 118 | Nephritis (HP:0000123) | 1.77807891 |
| 119 | Widely spaced teeth (HP:0000687) | 1.77727300 |
| 120 | Exocrine pancreatic insufficiency (HP:0001738) | 1.77398263 |
| 121 | Difficulty running (HP:0009046) | 1.76507543 |
| 122 | Dicarboxylic aciduria (HP:0003215) | 1.75788984 |
| 123 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75788984 |
| 124 | Abnormality of the gallbladder (HP:0005264) | 1.75667140 |
| 125 | Fair hair (HP:0002286) | 1.75349218 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74489874 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.74489874 |
| 128 | Action tremor (HP:0002345) | 1.72676495 |
| 129 | Atonic seizures (HP:0010819) | 1.72537381 |
| 130 | Flat acetabular roof (HP:0003180) | 1.72218298 |
| 131 | Pulmonary embolism (HP:0002204) | 1.71840801 |
| 132 | Thrombophlebitis (HP:0004418) | 1.71727927 |
| 133 | Vomiting (HP:0002013) | 1.71531890 |
| 134 | Abnormal tarsal ossification (HP:0008369) | 1.71001156 |
| 135 | Epileptic encephalopathy (HP:0200134) | 1.70551716 |
| 136 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.70036623 |
| 137 | Cerebral edema (HP:0002181) | 1.69801154 |
| 138 | Menorrhagia (HP:0000132) | 1.69749671 |
| 139 | Generalized hypopigmentation of hair (HP:0011358) | 1.69186957 |
| 140 | Turricephaly (HP:0000262) | 1.68976915 |
| 141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68234549 |
| 142 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68234549 |
| 143 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68234549 |
| 144 | Abnormality of vitamin metabolism (HP:0100508) | 1.67767764 |
| 145 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.67462887 |
| 146 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.67460320 |
| 147 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.65133605 |
| 148 | Subaortic stenosis (HP:0001682) | 1.65133605 |
| 149 | Narrow palate (HP:0000189) | 1.64793793 |
| 150 | Dysmetric saccades (HP:0000641) | 1.64379620 |
| 151 | Dysostosis multiplex (HP:0000943) | 1.63657020 |
| 152 | Obstructive sleep apnea (HP:0002870) | 1.63128545 |
| 153 | Germ cell neoplasia (HP:0100728) | 1.62733783 |
| 154 | Ventricular arrhythmia (HP:0004308) | 1.60652180 |
| 155 | Abnormality of potassium homeostasis (HP:0011042) | 1.60590303 |
| 156 | Thin bony cortex (HP:0002753) | 1.60589554 |
| 157 | Stomach cancer (HP:0012126) | 1.60131299 |
| 158 | Absent speech (HP:0001344) | 1.59941002 |
| 159 | Arterial tortuosity (HP:0005116) | 1.59000910 |
| 160 | Optic neuritis (HP:0100653) | 1.58113420 |
| 161 | Retrobulbar optic neuritis (HP:0100654) | 1.58113420 |
| 162 | Heart block (HP:0012722) | 1.57331836 |
| 163 | Orchitis (HP:0100796) | 1.57314403 |
| 164 | Widely patent fontanelles and sutures (HP:0004492) | 1.56946282 |
| 165 | Potter facies (HP:0002009) | 1.56140032 |
| 166 | Facial shape deformation (HP:0011334) | 1.56140032 |
| 167 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.55408496 |
| 168 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.55309435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 2.89791557 |
| 2 | BCKDK | 2.79044599 |
| 3 | SIK1 | 2.77415074 |
| 4 | INSRR | 2.70104166 |
| 5 | FGFR4 | 2.41006923 |
| 6 | ERN1 | 2.25140949 |
| 7 | TAOK3 | 2.21370090 |
| 8 | MAP2K4 | 2.11635621 |
| 9 | EPHA4 | 2.05760855 |
| 10 | DAPK2 | 2.02110128 |
| 11 | PRPF4B | 1.74630700 |
| 12 | ERBB4 | 1.74268753 |
| 13 | MST1R | 1.72940992 |
| 14 | PIK3CG | 1.67052512 |
| 15 | MAP3K2 | 1.56423491 |
| 16 | TRPM7 | 1.53162775 |
| 17 | EPHB1 | 1.45071128 |
| 18 | FGFR2 | 1.41710601 |
| 19 | CAMK1G | 1.36300281 |
| 20 | PTK6 | 1.36117076 |
| 21 | CAMK1D | 1.34687725 |
| 22 | NTRK3 | 1.31415818 |
| 23 | STK39 | 1.30495474 |
| 24 | IRAK1 | 1.28534512 |
| 25 | STK38 | 1.28410282 |
| 26 | LATS1 | 1.24675244 |
| 27 | NTRK1 | 1.22796245 |
| 28 | STK38L | 1.19637276 |
| 29 | RIPK4 | 1.18154262 |
| 30 | RIPK1 | 1.16329273 |
| 31 | KSR2 | 1.15154034 |
| 32 | PIK3CA | 1.13854490 |
| 33 | ACVR1B | 1.13114897 |
| 34 | JAK1 | 1.09945319 |
| 35 | OBSCN | 1.09219325 |
| 36 | MYLK | 1.08842336 |
| 37 | PAK3 | 1.06351084 |
| 38 | MAPK15 | 1.04015966 |
| 39 | OXSR1 | 1.03573682 |
| 40 | MAP3K4 | 1.03530344 |
| 41 | IKBKE | 1.01051848 |
| 42 | CAMKK1 | 1.00636370 |
| 43 | HIPK2 | 0.99725889 |
| 44 | JAK2 | 0.99197674 |
| 45 | MARK2 | 0.99147203 |
| 46 | MAP3K7 | 0.98539271 |
| 47 | MAP3K13 | 0.98216143 |
| 48 | NLK | 0.97045246 |
| 49 | PDPK1 | 0.96475608 |
| 50 | SGK3 | 0.94635450 |
| 51 | BRD4 | 0.93953341 |
| 52 | AKT3 | 0.92762497 |
| 53 | BMPR2 | 0.92176994 |
| 54 | WNK4 | 0.92104915 |
| 55 | RET | 0.91988918 |
| 56 | PINK1 | 0.90845473 |
| 57 | SGK223 | 0.88535994 |
| 58 | SGK494 | 0.88535994 |
| 59 | TRIB3 | 0.87724715 |
| 60 | ABL2 | 0.87605118 |
| 61 | CHUK | 0.87168903 |
| 62 | PRKAA2 | 0.87037216 |
| 63 | MAP3K9 | 0.85398614 |
| 64 | PRKCQ | 0.84718784 |
| 65 | MAP3K14 | 0.84206909 |
| 66 | CAMK2G | 0.83923105 |
| 67 | EPHA3 | 0.81073142 |
| 68 | PRKCZ | 0.80299374 |
| 69 | TBK1 | 0.80053032 |
| 70 | IRAK2 | 0.79776434 |
| 71 | FER | 0.78733459 |
| 72 | PDGFRB | 0.78129874 |
| 73 | SGK2 | 0.78127603 |
| 74 | PTK2 | 0.77051603 |
| 75 | PKN1 | 0.76840651 |
| 76 | MAPK12 | 0.76123682 |
| 77 | MAP3K1 | 0.75443410 |
| 78 | PKN2 | 0.75421330 |
| 79 | CDC42BPA | 0.74833197 |
| 80 | MAP3K6 | 0.74826215 |
| 81 | PDK1 | 0.74150336 |
| 82 | PRKCH | 0.72509020 |
| 83 | MAP3K3 | 0.72212716 |
| 84 | NEK6 | 0.72136084 |
| 85 | SIK2 | 0.70761807 |
| 86 | GSK3A | 0.70410511 |
| 87 | TGFBR2 | 0.70244464 |
| 88 | CDK12 | 0.70223861 |
| 89 | ZAP70 | 0.69578323 |
| 90 | MET | 0.68541759 |
| 91 | SIK3 | 0.68270410 |
| 92 | MAPK11 | 0.68029440 |
| 93 | MAPKAPK3 | 0.66290453 |
| 94 | ERBB2 | 0.66005128 |
| 95 | CAMKK2 | 0.65652354 |
| 96 | NEK9 | 0.65531423 |
| 97 | CSNK1G2 | 0.64670354 |
| 98 | MARK3 | 0.63381115 |
| 99 | MAP2K1 | 0.62589195 |
| 100 | PRKACG | 0.62456004 |
| 101 | CAMK4 | 0.62375885 |
| 102 | FGFR3 | 0.61902801 |
| 103 | MARK1 | 0.61770437 |
| 104 | TNK2 | 0.61071472 |
| 105 | MAPK13 | 0.60452921 |
| 106 | PHKG2 | 0.60133498 |
| 107 | PHKG1 | 0.60133498 |
| 108 | MAP2K7 | 0.59709184 |
| 109 | PRKAA1 | 0.59186375 |
| 110 | IRAK4 | 0.58907021 |
| 111 | MINK1 | 0.58866759 |
| 112 | PAK6 | 0.58123083 |
| 113 | ITK | 0.57901097 |
| 114 | CAMK2A | 0.57820327 |
| 115 | LMTK2 | 0.57539558 |
| 116 | NUAK1 | 0.57402327 |
| 117 | CSK | 0.56517883 |
| 118 | CASK | 0.55921894 |
| 119 | DMPK | 0.55817266 |
| 120 | GRK5 | 0.55589127 |
| 121 | MATK | 0.55333186 |
| 122 | RPS6KB1 | 0.55316672 |
| 123 | DYRK1B | 0.55285609 |
| 124 | STK24 | 0.54400990 |
| 125 | CAMK2B | 0.53884734 |
| 126 | PRKCG | 0.53580651 |
| 127 | PRKG2 | 0.53462215 |
| 128 | MAPK7 | 0.53074509 |
| 129 | IKBKB | 0.53022444 |
| 130 | CDK5 | 0.51537230 |
| 131 | BLK | 0.49870862 |
| 132 | WNK1 | 0.49687743 |
| 133 | PRKCE | 0.49671084 |
| 134 | CAMK2D | 0.48482660 |
| 135 | TYK2 | 0.47129452 |
| 136 | GRK6 | 0.46866468 |
| 137 | IGF1R | 0.46164208 |
| 138 | SGK1 | 0.45940267 |
| 139 | PTK2B | 0.45112745 |
| 140 | MAP2K6 | 0.44529782 |
| 141 | PRKD1 | 0.43538943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.19476895 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.14725065 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.01363540 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94075264 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90729595 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50290207 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.46694704 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.38574799 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22178837 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18608756 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17051392 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.10252399 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.96562045 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96383556 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.90766025 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85236330 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85210862 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.80811369 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.78978637 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76897804 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74077071 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69393636 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68509379 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66074820 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63962814 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63597269 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.62690043 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59189361 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54705630 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.50488419 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50224003 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40731275 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.40647740 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31608230 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26767635 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.26250118 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.22741399 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20942517 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19829813 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18750996 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18647255 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17809173 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.17428043 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14683375 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14530503 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10426716 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03728720 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00789588 |
| 49 | Long-term potentiation_Homo sapiens_hsa04720 | 0.90187912 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86960361 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86103381 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80532645 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.80027863 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79422264 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77837455 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77143574 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76482054 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76214012 |
| 59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75290337 |
| 60 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75235027 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74453215 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73465805 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70560916 |
| 64 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70487797 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70413176 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.70296668 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69384044 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68675433 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68257785 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67929476 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67297218 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65988522 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65230273 |
| 74 | Long-term depression_Homo sapiens_hsa04730 | 0.64868633 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63332851 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62624726 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62580822 |
| 78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62256429 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60894498 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60478479 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60159214 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59265110 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58992083 |
| 84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.57871783 |
| 85 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57579947 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56144507 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.55936214 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55399324 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.54311581 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53593069 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53539769 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.52632503 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51240380 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51027944 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.50307859 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49832421 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49583325 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49219459 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49053875 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48004991 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47144294 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47128774 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46982964 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.39876183 |
| 105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39177699 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39141923 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38649905 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36365624 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35630873 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33832860 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33720516 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30933298 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28943464 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27229800 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25469663 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25301844 |
| 117 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.24486102 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24349786 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.24208817 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.23599446 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23472098 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21719681 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21335033 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.20787875 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.17634509 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15463123 |
| 127 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.14377726 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.13510558 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12594578 |
| 130 | Renin secretion_Homo sapiens_hsa04924 | 0.12245212 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.11600585 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.09740502 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07675455 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.07056975 |
| 135 | Cocaine addiction_Homo sapiens_hsa05030 | 0.06771186 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06716235 |
| 137 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.06566357 |
| 138 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.06214337 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.04193436 |
| 140 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.04136099 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.03661026 |
| 142 | Lysosome_Homo sapiens_hsa04142 | 0.03477462 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.03152744 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02833412 |

